Exciting times 🎉 We have raised $2.6 million for PeptiCov, our spin-off company combatting Covid-19.

View Article

PeptiCov will use Pepticom’s AI technology to design, discover and develop novel peptide molecules. Read more in CTech by Calcalist here:

https://lnkd.in/eM74nGA